Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 249-616-3 | CAS number: 29420-49-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2001
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Justification for type of information:
- The study was not conducted in strict compliance with FDA GLP. However, the study was conducted according to the protocol and applicable standard operating procedures of the research laboratory. All study procedues, data recording and reporting were performed in a manner consistent with the standard of GLPs.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2001
Materials and methods
- Objective of study:
- distribution
- excretion
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- The objectives of the study were to determine the concentration of the test article in serum and to estimate urinary clearance at various times following administration of a single intravenous dose to monkeys.
- GLP compliance:
- no
Test material
- Reference substance name:
- Potassium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulphonate
- EC Number:
- 249-616-3
- EC Name:
- Potassium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulphonate
- Cas Number:
- 29420-49-3
- Molecular formula:
- C4HF9O3S.K
- IUPAC Name:
- potassium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: EO4/L-1
- Expiration date of the lot/batch: No data
- Purity test date: 26 February, 2001
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: The test article was disolved in sterile saline prior to dosing.
- Final dilution of a dissolved solid, stock liquid or gel: The test article was prepared to deliver 10 mg/kg to each animal at a dose volume of 2 mL/kg.
FORM AS APPLIED IN THE TEST: The test article was dissolved in sterile saline. - Radiolabelling:
- no
Test animals
- Species:
- monkey
- Strain:
- other:
- Details on species / strain selection:
- Cynomolgus monkeys were utilized for this study.
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River BRF, Inc. (Houston, TX).
- Age at study initiation: No data
- Weight at study initiation: Males: 4.4-5.8 kg, Females: 3.3-3.9 kg
- Housing: Individually in stainless steel cages.
- Diet (e.g. ad libitum): Certified commercial dry monkey chow #5048 (PMI Feeds, Inc., St. Louis, MO) fed to the monkeys 2-3 times each day.
- Water (e.g. ad libitum): Tap water ad libitum.
- Acclimation period: Unspecified quarantine period.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-21.3
- Humidity (%): 22.2-65.7
- Air changes (per hr): No data
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- intravenous
- Vehicle:
- physiological saline
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: The test article was dissolved in sterile saline.
- Duration and frequency of treatment / exposure:
- Each animal received a single intravenous bolus dose of 10 mg/kg of the test article.
Doses / concentrations
- Dose / conc.:
- 10 mg/kg bw (total dose)
- Remarks:
- Doses were administered at a volume of 2 mL/kg body weight.
- No. of animals per sex per dose / concentration:
- 3
- Control animals:
- no
- Positive control reference chemical:
- None
- Details on study design:
- Three male and three female monkeys were administered a single IV bolus dose of 10 mg/kg of perfluorobutanesulfonate, potassium salt. At various times through 31 days after dosing, serum and urine (24-hour collections) samples were obtained and analyzed by HPLC/MS/MS for levels of intact perfluorobutanesulfonate.
- Dose selection rationale: No data
- Rationale for animal assignment: No randomization was required as there was only one treatment group. - Details on dosing and sampling:
- TOXICOKINETIC / PHARMACOKINETIC STUDY
- Tissues and body fluids sampled: urine, faeces, serum
- Time and frequency of sampling: Urine and feces were collected for 24-hour intervals on the following days: prior to dose administration (Day -1; baseline), on Day 0 (0-24 hours postdose), and on Days 7 and 14. The volume of each urine sample was measured upon collection. Samples were stored frozen at -20 °C or below. Blood samples (approximately 2 mL) were collected from each primate at approximately 0 (predose) minutes; 2, 4, 8, 24, and 48 hours; and on Days 4, 7, 11, 14, and 31 postdose. Samples were collected into tubes without anticoagulant and were allowed to clot at room temperature. The blood samples were then centrifuged, and the serum separated and stored frozen (-20 °C or below) until analyzed.
CHARACTERISATION STUDIES
- Tissues and body fluids sampled urine, feces, serum
- Time and frequency of sampling: Urine and feces were collected for 24-hour intervals on the following days: prior to dose administration (Day -1; baseline), on Day 0 (0-24 hours postdose), and on Days 7 and 14. The volume of each urine sample was measured upon collection. Samples were stored frozen at -20 °C or below. Blood samples (approximately 2 mL) were collected from each primate at approximately 0 (predose) minutes; 2, 4, 8, 24, and 48 hours; and on Days 4, 7, 11, 14, and 31 postdose. Samples were collected into tubes without anticoagulant and were allowed to clot at room temperature. The blood samples were then centrifuged, and the serum separated and stored frozen (-20 °C or below) until analyzed.
- From how many animals: Samples were taked from all three males and all three females.
- Method type(s) for identification: HPLC-MS-MS
- Limits of detection and quantification: LOD: 0.5 ng/mL, LOQ: 1 ng/mL
Results and discussion
Main ADME resultsopen allclose all
- Type:
- distribution
- Results:
- The volume of distribution at steady state was 254 or 255 mL/kg in male or female monkeys, respectively.
- Type:
- excretion
- Results:
- The mean terminal serum half-life of the test article in male and female monkeys was 3.5-4.0 days. Urinary excretion was the major route of elimination of unchanged test article.
Toxicokinetic / pharmacokinetic studies
- Details on distribution in tissues:
- The volume of distribution at steady state was 254 or 255 mL/kg in male or female monkeys, respectively.
- Details on excretion:
- Mean half-life values for the test article in serum were 0.04, 0.55, and 4.0 days in male monkeys and 0.06, 0.47, and 3.5 days in female monkeys.
Toxicokinetic parameters
- Key result
- Test no.:
- #1
- Toxicokinetic parameters:
- half-life 1st: 3.5-4.0 days
- Remarks:
- Male and female monkeys.
Metabolite characterisation studies
- Metabolites identified:
- no
Applicant's summary and conclusion
- Conclusions:
- Based on the results of the study, the mean terminal half-life values for the test article in male and female monkeys was 3.5 - 4.0 days. In monkeys, urinary excretion was a major route of elimination of unchanged test article.
- Executive summary:
The pharmacokinetics and urinary excretion of the test article were investigated in male and female cynomolgus monkeys. The study was not conducted in strict compliance with FDA GLP. However, the study was conducted according to the protocol and applicable standard operating procedures of the research laboratory. All study procedues, data recording and reporting were performed in a manner consistent with the standard of GLPs. Three male and three female monkeys were administered a single IV bolus dose of 10 mg/kg of test article. Urine and feces were collected for 24-hour intervals on the following days: prior to dose administration (Day -1; baseline), on Day 0 (0-24 hours postdose), and on Days 7 and 14. The volume of each urine sample was measured upon collection. Blood samples (approximately 2 mL) were collected from each primate at approximately 0 (predose) minutes; 2, 4, 8, 24, and 48 hours; and on Days 4, 7, 11, 14, and 31 postdose. Samples were collected into tubes without anticoagulant and were allowed to clot at room temperature. The blood samples were then centrifuged, and the serum separated and stored frozen (-20 °C or below) until analyzed by HPLC/MS/MS for levels of intact test article. The lower limit of detection of the analytical method was 0.5 ng/mL. No sex-related differences in serum concentrations of test article were apparent among the six dosed monkeys. In individual animals, the concentration of test article in serum ranged from 19,628 to 61,740 ng/mL at 2 hours after dosing (earliest time point). By 48 hours after dosing, the serum concentration of test article ranged from 463 to 8,172 ng/mL in individual monkeys. The test article was not detectable in serum collected from any monkey on Day 31 post dose. The serum concentration versus time data were best fit to a three-compartment model. Mean serum half-life values for the test article were 0.04, 0.55, and 4.0 days in male monkeys, and 0.06, 0.47, and 3.5 days in female monkeys. The mean AUC value calculated from serum concentrations of the test article was 24,258 or 35,401 ng.day/mL in male or female monkeys, respectively. The total body clearance of the test article was 511 mL/day/kg in male monkeys and 368 mL/day/kg in female monkeys. The volume of distribution at steady state (Vdss) was 254 or 255 mL/kg in male or female monkeys, respectively. For 5 of 6 monkeys, from 33.8 to 86.8% of the dose was recovered in urine within 24 hours after administration of the test article. On Day 14, individual monkeys excreted less than 0.01% of the dose within a 24-hour interval. Based on the results of the study, the mean terminal half-life values for the test article in male and female monkeys was 3.5 - 4.0 days. In monkeys, urinary excretion was a major route of elimination of unchanged test article.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.